We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Algeta Announces first US Patient Randomized in ALSYMPCA Phase III Study

News   Dec 16, 2009

 
Algeta Announces first US Patient Randomized in ALSYMPCA Phase III Study
 
 
 

RELATED ARTICLES

A DIY 'Just-add-water' Malaria Detection Kit is Ready to Launch

News

A 'just-add-water' diagnostic test for malaria has been designed by Australian scientists, and it's ready to go.

READ MORE

First-of-its-Kind Parkinson’s Disease Biomarker Guidelines Invigorates Drive for Treatments

News

These guidelines aim to improve Parkinson's treatment development and collaboration, and provide research principles.

READ MORE

HIV Therapy Reduces Virus and Boosts Immunity in Drug-Resistant Patients

News

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE